GlassScriptPhysician profile
Sooyeon Choi
NPI 1548526205
$5,344.23
in general payments reported to CMS, 2019-2025
48 companies · $705 in 2025
The $705 reported for 2025 was more than what 87% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $192 · 2021: $605 · 2022: $1,394 · 2023: $1,311 · 2024: $667 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,683.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,218.34 | 2019-2024 | Lo Loestrin Fe, Liletta, Orilissa |
| Myovant Sciences INC. | $534.87 | 2021-2022 | |
| Pfizer INC. | $418.43 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $353.89 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $339.21 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $321.83 | 2021-2025 | |
| Organon LLC | $287.35 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $181.42 | 2019-2022 | |
| Amgen INC. | $176.34 | 2019-2022 | |
| Shield Therapeutics INC | $172.63 | 2023-2025 | Accrufer |
| Agile Therapeutics, INC. | $98.11 | 2022-2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $94.92 | 2022-2025 | |
| Avion Pharmaceuticals | $85.65 | 2020-2023 | Balcoltra |
| Millicent US INC | $74.98 | 2023-2025 | Intrarosa, Femlyv |
| Cumberland Pharmaceuticals, INC. | $71.49 | 2019-2025 | Caldolor |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $62.64 | 2022-2025 | Ligasure |
| Minerva Surgical, INC | $54.49 | 2021 | |
| Davol INC. | $54.23 | 2020-2022 | |
| Hologic Sales and Service, LLC | $44.78 | 2023-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Lupin INC. | $42.44 | 2019-2021 | |
| Daiichi Sankyo INC. | $42.08 | 2022-2023 | Injectafer |
| Amag Pharmaceuticals, INC. | $39.18 | 2019 | |
| Ethicon US, LLC | $37.83 | 2024 | Harmonic, Vistaseal, Enseal X1 |
| Exact Sciences Corporation | $37.25 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $35.80 | 2019-2020 | |
| Integra Lifesciences Corporation | $35.50 | 2022-2024 | Medihoney, Biofix, Biodoptix |
| Smith+Nephew, INC. | $35.35 | 2024-2025 | Pico 14, Stravix |
| Exeltis, USA INC. | $34.41 | 2023 | Slynd |
| Sage Therapeutics, LLC | $29.45 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $25.08 | 2025 | Exparel |
| Innovation Technologies INC | $24.21 | 2023 | Irrisept |
| Olympus America INC. | $23.79 | 2025 | Olympus |
| Axonics, INC. | $21.34 | 2023 | Bulkamid |
| Dexcom, INC. | $20.30 | 2023 | Dexcom G6 Transmitter |
| Vertical Pharmaceuticals, LLC | $19.28 | 2019 | |
| Channel Medsystems, INC. | $19.15 | 2023 | |
| Mycovia Pharmaceuticals, INC. | $19.08 | 2023 | Vivjoa |
| Evofem Biosciences, INC. | $18.28 | 2022 | |
| Meditrina | $18.05 | 2025 | |
| Idorsia Pharmaceuticals US INC | $18.00 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $16.97 | 2022 | |
| Duchesnay USA Incorporated | $15.97 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.81 | 2025 | Qelbree |
| Kedrion Biopharma INC. | $14.94 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.72 | 2019 | |
| Coopersurgical, INC. | $13.14 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Allergan, INC. | $11.23 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sooyeon Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.